Screen capture of BMJ webpage https://www.bmj.com/content/391/bmj-2024-083382 Research RETRACTED: Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) BMJ 2025; 391 doi: https://doi.org/10.1136/bmj-2024-083382 Published 29 October 2025) Cite this as: BMJ 2025;391:e083382 This article has corrections, but has also been retracted. Please see: EXPRESSION OF CONCERN: Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial - November 12, 2025 CORRECTION: Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) - March 31, 2026 RETRACTION: Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) - March 31, 2026 Armin Attar, professor1,Seyed Alireza Mirhosseini, medical doctor1,Ahmad Monabati, professor2 3,Mohammad Kasaei, assistant professor1,Firoozeh Abtahi, associate professor1,Yahya Kiwan, assistant professor4,Massoud Vosough, associate professor5,Negar Azarpira, professor6
📣The [faked] PREVENT-TAHA8 trial paper was #retracted from @bmj.com after 5 long months 😅
🤝 well done @deevybee.bsky.social @steamtraen.eu @sophieehill.bsky.social @wjst.de @ioanaacristea.bsky.social @gidmk.bsky.social P.T. Wilmhurst and anonymous @pubpeer.com users
#ResearchIntegrity 🔍 #FoSci